Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

Liver Int

Department of Infectious Diseases, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Published: February 2017

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13289DOI Listing

Publication Analysis

Top Keywords

four-year entecavir
4
entecavir therapy
4
therapy reduces
4
reduces hepatocellular
4
hepatocellular carcinoma
4
carcinoma cirrhotic
4
cirrhotic events
4
events mortality
4
mortality chronic
4
chronic hepatitis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!